Mattias Rantalainen, co-founder, CTO of Stratipath, and coordinator of SwAIPP (Sweden AI Precision Pathology), is being interviewed by Vinnova regarding innovation in precision medicine.

“For us, building evidence around the solutions we develop is important. We collaborate internationally in several ongoing validation studies. We also gain synergies by conducting overlapping activities with a Nordic consortium. In the long run, it is also important to disseminate our solutions outside of Sweden,” says Mattias Rantalainen at SwAIPP.